cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Kezar Life Sciences Inc
5 own
7 watching
Current Price
$0
$-0.06
(-0.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
499.8M
52-Week High
52-Week High
18.55
52-Week Low
52-Week Low
4.305
Average Volume
Average Volume
0.07M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization499.8M
icon52-Week High18.55
icon52-Week Low4.305
iconAverage Volume0.07M
iconDividend Yield--
iconP/E Ratio--
What does the Kezar Life Sciences Inc do?
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company s lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.
Read More
How much money does Kezar Life Sciences Inc make?
News & Events about Kezar Life Sciences Inc.
Zolmax
1month ago
Kezar Life Sciences, Inc. (NASDAQ:KZR Get Rating) was the target of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 6,600,000 shares, a decline of 7.3% from the October 31st total of 7,120,000 shares. Based on an average ...
Business Wire
3 months ago
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that it presented the complete data set from the MISSION Phase 2 clinical trial evaluating zetomipzomib, a...
Business Wire
3 months ago
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that four posters will be presented at the upcoming American Society of Nephrologys (ASN) Kidney Week 2022...
PR Newswire
7 months ago
Thinking about buying stock in Autohome, Bed Bath & Beyond, Kezar Life Sciences, General Electric, or Delta Air Lines? Thinking about buying stock in Autohome, Bed Bath & Beyond, Kezar Life Sciences, General Electric, or Delta Air Lines? PR Newswire NEW YORK, June 29, 2022 NEW YORK...
Globe Newswire
7 months ago
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Kezar Life Sciences (NASDAQ: KZR), Nova Mentis Life Sciences (OTC: NMLSF), Agile Therapeutics (NASDAQ: AGRX), and ...
Frequently Asked Questions
Frequently Asked Questions
What is Kezar Life Sciences Inc share price today?
plus_minus_icon
Can Indians buy Kezar Life Sciences Inc shares?
plus_minus_icon
How can I buy Kezar Life Sciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Kezar Life Sciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Kezar Life Sciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Kezar Life Sciences Inc?
plus_minus_icon
What is today’s market capitalisation of Kezar Life Sciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Kezar Life Sciences Inc?
plus_minus_icon
What percentage is Kezar Life Sciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Kezar Life Sciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.06
(-0.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00